Adverum Biotechnologies
ADVM
ADVM
59 hedge funds and large institutions have $33.1M invested in Adverum Biotechnologies in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 22 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
36% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 22
40% less capital invested
Capital invested by funds: $55.6M → $33.1M (-$22.5M)
71% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 24
Holders
59
Holding in Top 10
2
Calls
$766K
Puts
$7K
Top Buyers
| 1 | +$3.23M | |
| 2 | +$435K | |
| 3 | +$426K | |
| 4 |
MAM
Monaco Asset Management
Monaco
|
+$252K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$74K |
Top Sellers
| 1 | -$5.31M | |
| 2 | -$1.79M | |
| 3 | -$1.02M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$528K |
| 5 |
BlackRock
New York
|
-$466K |